Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × axatilimab × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Other hematologic neoplasm 3 Tumor-Agnostic 2 Myeloid 2 Lymphoid 1 Gastrointestinal 1

Conditions

Hodgkin Disease 1

Interventions

Rituximab 1365 Cyclophosphamide 1292 Vincristine 661 Doxorubicin 581 Etoposide 526 Prednisone 505 Cytarabine 480 fludarabine 456 Methotrexate 441 Dexamethasone 409 fludarabine phosphate 395 Lenalidomide 345 Filgrastim 342 Bendamustine Hydrochloride 272 Radiotherapy 264 venetoclax 252 ibrutinib 249 Peripheral Blood Stem Cell Transplantation 233 Melphalan 229 obinutuzumab 227 Granulocyte Colony-Stimulating Factor 211 Bortezomib 204 Gemcitabine 199 Whole-Body Irradiation 184 Busulfan 184 Mycophenolic Acid 173 Tacrolimus 163 Specimen Handling 155 Calcium Dobesilate 150 Magnetic Resonance Spectroscopy 144

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05723055 2025-11-26

NAHL

University of Utah

Phase 2 Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡